Clinical implications of systemic inflammatory response markers as independent prognostic factors in colorectal cancer patients

Cancer Research and Treatment

Volumn 46, Issue 1, 2014, Pages 65-73

  Paik, Kwang Yeol ^a   Lee, In Kyu ^a   Lee, Yoon Suk ^a   Sung, Na Young ^b   Kwon, Taek Soo ^a  

^a The Catholic University of Korea   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Colorectal neoplasms; Inflammation; Perioperative period; Prognosis

Indexed keywords

EID: 84893965177     PISSN: 15982998     EISSN: 20059256     Source Type: Journal    
DOI: 10.4143/crt.2014.46.1.65     Document Type: Article

References (14)

1. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420:860-7.
2. Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res. 2006;4:221-33.
3. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436-44.
4. Lee IK, Vansaun MN, Shim JH, Matrisian LM, Gorden DL. Increased metastases are associated with inflammation and matrix metalloproteinase-9 activity at incision sites in a murine model of peritoneal dissemination of colorectal cancer. J Surg Res. 2013;180:252-9.
5. McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009;12:223-6.
6. Leitch EF, Chakrabarti M, Crozier JE, McKee RF, Anderson JH, Horgan PG, et al. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer. 2007;97:1266-70.
7. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91:181-4.
8. Smith RA, Bosonnet L, Raraty M, Sutton R, Neoptolemos JP, Campbell F, et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg. 2009;197:466-72.
9. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. AJCC cancer staging handbook: from the AJCC cancer staging manual. New York: Springer; 2002.
10. Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg. 2007;246: 1047-51.
11. Crozier JE, Leitch EF, McKee RF, Anderson JH, Horgan PG, McMillan DC. Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer. Am J Surg. 2009;197:544-9.
12. Okuse T, Chiba T, Katsuumi I, Imai K. Differential expression and localization of WNTs in an animal model of skin wound healing. Wound Repair Regen. 2005;13:491-7.
13. Rubin P, Constine L, Williams J. Late effects of cancer treatment. In: Perez CA, Brady LW, editors. Principles and practice of radiation oncology. Philadelphia: Lippincott-Raven; 1998. p. 194-211.
14. Milsom JW, Senagore A, Walshaw RK, Mostosky UV, Wang P, Johnson W, et al. Preoperative radiation therapy produces an early and persistent reduction in colorectal anastomotic blood flow. J Surg Res. 1992;53:464-9.